Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G I Papakostas

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Translational Psychiatry|March 22, 2017
Experimental medication treatment approaches for depressionD F Ionescu, G I Papakostas
Molecular Psychiatry|July 8, 2015
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorderG I Papakostas, D F Ionescu
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorderG I Papakostas, C H Homberger, M Fava
Psychological Medicine|May 7, 2010
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysisJ Guidi, G A Fava, M Fava, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 14, 2011
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderY Levkovitz, J E Alpert, C E Brintz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 15, 2011
SAMe and sexual functioningC M Dording, D Mischoulon, I Shyu, et al.
Psychological Medicine|July 21, 2004
Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetineT Petersen, R Harley, G I Papakostas, et al.
Psychopharmacology Bulletin|October 26, 2002
A survey of prescribing preferences in the treatment of refractory depression: recent trendsR Kornbluh, G I Papakostas, T Petersen, et al.
Pharmacopsychiatry|May 27, 2015
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical TrialJ Sarris, L H Price, L L Carpenter, et al.
Molecular Psychiatry|December 14, 2011
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication studyG I Papakostas, R C Shelton, G Kinrys, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Translational Psychiatry|March 22, 2017
Experimental medication treatment approaches for depressionD F Ionescu, G I Papakostas
Molecular Psychiatry|July 8, 2015
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorderG I Papakostas, D F Ionescu
Journal of Psychopharmacology (Oxford, England)|March 1, 2008
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorderG I Papakostas, C H Homberger, M Fava
Psychological Medicine|May 7, 2010
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysisJ Guidi, G A Fava, M Fava, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 14, 2011
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorderY Levkovitz, J E Alpert, C E Brintz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 15, 2011
SAMe and sexual functioningC M Dording, D Mischoulon, I Shyu, et al.
Psychological Medicine|July 21, 2004
Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetineT Petersen, R Harley, G I Papakostas, et al.
Psychopharmacology Bulletin|October 26, 2002
A survey of prescribing preferences in the treatment of refractory depression: recent trendsR Kornbluh, G I Papakostas, T Petersen, et al.
Pharmacopsychiatry|May 27, 2015
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical TrialJ Sarris, L H Price, L L Carpenter, et al.
Molecular Psychiatry|December 14, 2011
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication studyG I Papakostas, R C Shelton, G Kinrys, et al.
Pageof 2